SUMMARY Effects of [Asul17]-eel calcitonin on gastric somatostatin and gastrin secretion were studied by using the isolated perfused rat stomach. [Asul 7]-eel calcitonin (10-9 -10-7M) caused a simultaneous dose-dependent increase of gastric somatostatin release and decrease of gastrin secretion, with a significant correlation between these two. The demonstration of calcitonin stimulation of gastric somatostatin release raises the possibility of somatostatin-mediated suppression of gastrin secretion by calcitonin. Animals were anaesthetised with pentobarbital (40 mg/kg) after an overnight fast. After a midline laparotomy, polyethylene cannulae were inserted into the left gastric artery and gastric vein. All other vessels and pancreas were carefully excluded by ligation. After cardial ligation, a catheter was inserted into the stomach through the pyloric ring to drain gastric juice. Infusion was then started with 4-6% dextran (mean mol.wt.70,000) Krebs-Ringer bicarbonate buffer containing 5.5 mM glucose (DKRBG) into the left gastric artery at a flow rate of 2 ml/min without recirculation. The perfusate was equilibrated with a gas phase of 95% 02/5% CO2 immediately before use and maintained at pH 7-4 and PaO2 350 mmHg. The entire perfusion system including the perfusate was kept at 37°C throughout the experiment. After the pre-stimulation period (20 minutes) perfused with DKRBG
In addition to its effects on bone and kidney as a hypocalcaemic agent, calcitonin was found to suppress various gastrointestinal functions,1-5 including secretion of gastrin and gastric acid.6,8 Recently, significant amounts of somatostatin, a potent inhibitor of gastric acid and gastrin secretion," 10 were demonstrated in the stomach by radioimmunoassayll 12 as well as by immunocytochemical technique. '3 More recently, we demonstrated somatostatin release from the stomach.14 In view of the location of somatostatin-producing D cells in the mucosa of the fundus and the antrum in the vicinity of the parietal cells and gastrinproducing G cells,15 16 an influence of gastric somatostatin on gastric acid and gastrin secretion was suggested. It therefore appeared worth while to investigate the effect of calcitonin on gastric somatostatin release with reference to gastrin secretion.
In the present study, we studied the effects of [Asul"7] 
Results
In the control experiments perfused only with DKRBG, somatostatin levels ranged from 130 ng/l to 218 ng/l (mean ±SEM: 176±5 ng/l), and gastrin levels from 165 ng/l to 250 ng/l (mean ±SEM: 223 ± 7 ng/), neither of which changed significantly throughout the perfusion period (Fig. 1) .
The infusion of [Asul"7] -eel calcitonin caused a significant and dose-related increase of gastric somatostatin secretion (Table, Fig 10 ng/l (P<005), and 340±21 ng/l (P<001) were obtained by 10-9, 10-8, and 10-7 M [Asul'71-eel calcitonin, respectively. In most experiments, the peak values were attained at 1 1-13 minutes after the start of [Asul"7] -eel calcitonin infusion (Fig. 1) . Conversely, [Asu' 7] -eel calcitonin elicited a significant decrease of gastrin secretion also in a dose-dependent fashion (Table, Fig. 1 ). The nadir of gastrin release caused by 10-9, 10-, and 10-7 M eel calcitonin was 184±11 ng/l (P<005 vs. control), 180±10 ng/1 (p<0.05), and 152 ±6 ng/l (p<0.05), respectively. The most prominent suppression of gastrin release INCREMENT OF SOMATOSTATIN RELEASE(p9) Fig. 2 Correlation between the increment of total amounts of somatostatin release and the decrement of total amounts ofgastrin secretion during the infusion of 109M (x ), 1 O-8I ((), and 1O-7M (0) of [Asul, calcitonin compared with the amounts released by the control.
coincided with the peak of gastric somatostatin release (Fig. 1) .
The total amounts of gastric somatostatin release and gastrin secretion during the infusion of _ eel calcitonin (15 min) are summarised in the Table. The increment in total somatostatin release and decrement in total gastrin secretion during the infusion of 10-9, 10-8, and 1O-7 M[Asul7]-eel calcitonin were plotted in Fig. 2 . A significant correlation (r=0.60, P<O0O1) was found between these two values.
Discussion
Calcitonin has been shown to suppress gastrin and gastric acid secretion in mammals,6 7 and it is suggested that it is a physiological regulator of gastrin and gastric acid secretion.8 However, the exact mechanism of calcitonin action on gastrin secretion has not been clarified. In view of the hypocalcaemic action of the peptide, the inhibitory action of calcitonin on gastrin secretion could be mediated by calcium depletion around the antral G cells. This is, however, unlikely, as such an effect of calcitonin was shown to occur without any significant change of the serum calcium levels,6 so that factors other than the changes in calcium concentration should be considered as the mechanism of calcitonin-induced suppression of gastrin secretion.
The present study clearly demonstrated the potent suppressive effect of calcitonin on gastrin secretion, confirming previous reports.7 As a constant level (2.5 mM) of calcium was supplied to the isolated perfused stomach in the present study, the suppressive effect of calcitonin on gastrin secretion was apparently not mediated by the change in the calcium concentration, though the subtle intra-and extracellular movement of calcium ions in the secretory cells cannot be excluded.
The most striking observation in the present study is the dose-related increase of gastric somatostatin release in response to [Asul 7]-eel calcitonin.
Somatostatin-producing D cells have been demonstrated within the antral mucosa in the vicinity of the G cells.'516 Furthermore, significant amounts of somatostatin have been found to be released from the stomach of dogs23 and rats in response to various stimuli. These findings'4 raise the possibility that gastrin secretion may be regulated by gastric somatostatin within the local area of the antral mucosa. In view of the simultaneous increase of somatostatin release and decrease of gastrin secretion with a significant mutual correlation, as well as the known potent inhibiting action of somatostatin on gastrin secretion, the suppression of gastrin secretion by calcitonin may, at least in part, be mediated by endogenous gastric somatostatin, though other possibilities independent of these two phenomena cannot be completely excluded.
The fact that both calcitonin and somatostatin inhibit histamine-and pentagastrin-induced gastric acid secretion610 may suggest a similar mechanism of action of these two substances in inhibiting gastric acid secretion. While somatostatin-secreting D cells are distributed both in the fundic and antral portions of the stomach," somatostatin released from the fundic region may act directly on parietal cells to inhibit acid secretion. It is thus possible that calcitonin-induced increase of somatostatin release demonstrated in the present study inhibits gastric acid secretion not only by decreasing gastrin release but also by a direct action on the parietal cells.
Recently, somatostatin-like immunoreactivity has been found to be present in the parafollicular cells of the rat thyroid gland24 known as the site of production of calcitonin, suggesting the intimate functional relationship between calcitonin and somatostatin, while the effect of somatostatin on calcitonin secretion still remains controversial. [25] [26] [27] The present data would suggest a new angle for the study of the interrelationship between gastrin and calcitonin. 
